Keyword: Cell Therapy


AstraZeneca Invests $245 Million in French Biotech Cellectis

02.11.2023 -

Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the...


Fluor Completes Bayer’s First Global Cell Therapy Launch Facility

23.10.2023 -

Fluor Corporation announced today that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Completion was...


Bayer Opens New Cell Therapy Production Facility in the US

10.10.2023 -

Bayer has opened a new cell therapy production plant in Berkeley, California, USA, for the production of of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an...


Lonza, Vertex Break Ground on New US Cell Therapy Plant

05.09.2023 -

Last week, Lonza and Vertex Pharmaceuticals broke ground on a new US facility in Portsmouth, New Hampshire, to manufacture cell therapies for diabetes.


Cellares Raises $255 Million for Cell Therapy Development Facility

24.08.2023 -

Cellares, a US-based integrated development and manufacturing organization (IDMO), has secured $255 million in Series C funding to establish a cell therapy development...


Adaptimmune and TCR2 Agree Merger

13.03.2023 -

Clinical stage biotechs Adaptimmune and TCR2 Therapeutics have agreed to merge, forming what they said would be a “preeminent cell therapy company focused on creating...


Catalent Opens Cell Therapy Facility in Belgium

13.12.2022 -

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.


Germany’s Merck Expands CDMO Footprint

19.10.2021 -

Germany’s Merck has opened its second production facility for viral vectors at Carlsbad, California, a move the company said significantly expands its global CDMO...